CIO
APRIL 17, 2024
Similarly, clothing brand Under Armour recently produced an ad that used AI-generated 3D models of the British boxer Anthony Joshua, based on videos they took of him in the past. As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on.
TechCrunch
JULY 14, 2021
One small company that stepped into the fray of swab production was the two-year-old OPT Industries, a Massachusetts-based company with 15 employees involved in additive manufacturing (think 3D printing) of dense microfiber structures. As COVID-19 surges, 3D printing is having a moment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
DECEMBER 2, 2020
Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.
TechCrunch
FEBRUARY 28, 2022
Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Instead, it’s developing a unit that 3D prints a dense network of microchannels that pass cells through the nutrients and oxygen they need.
TechCrunch
APRIL 2, 2022
Mooji Meats: Speedy 3D printing whole cuts. The company has developed a 3D printer capable of producing whole cuts of meat using plant protein or cultured meat cells. They’re developing a 3D-printed cut of Wagyu beef, and expect a prototype to be viable for taste tests within six months, co-founder Insa Mohr told TechCrunch.
TechCrunch
DECEMBER 15, 2021
Prellis Biologics , a company developing the tools to create 3D-printed organs, announced a $14.5 Up until this point, Prellis has focused on 3D printing vascular scaffolds that would allow companies to grow healthy and oxygenated human organs (or miniature versions, called organoids) for drug testing, and eventually transplant.
TechCrunch
FEBRUARY 9, 2021
Yet, the R&D process for drug discovery relies on 2D monitors, keyboard, and mouse, which limits the understanding of complex 3D structures or interactions and contributes to massive R&D costs averaging $2.5B “Understanding structure empowers our users to understand how their designs function,” he wrote in an email. per drug.”.
Expert insights. Personalized for you.
298 
Let's personalize your content